bioMérieux S.A. (BIM.PA)

100,70 -0,70 (-0,69%) Börsenschluss: 05:35PM CEST

bioMérieux S.A.

376 Chemin De l’Orme
Marcy l'Étoile 69280
France
33 4 78 87 20 00
https://www.biomerieux.com

Sektor(en): Healthcare
Branche: Diagnostics & Research
Vollzeitmitarbeiter: 13.409

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Pierre Boulud	Chief Executive Officer	1,35M	N/A	1971
Mr. Guillaume Bouhours	Executive VP of Purchasing and Information Systems & CFO	N/A	N/A	1976
Sylvain Morgeau	Investor Relations	N/A	N/A	N/A
Ms. Audrey Dauvet	Executive Vice President of Legal, Corporate Integrity & Public Affairs	N/A	N/A	1974
Ms. Valerie Leylde	Executive Vice President of Human Resources, Communications & CSR	N/A	N/A	N/A
Mr. Pierre Charbonnier	Executive Vice President of Global Quality, Manufacturing & Supply Chain	N/A	N/A	N/A
Mr. Yasha Mitrotti	Executive Vice President of Industrial Applications	N/A	N/A	N/A
Mr. Frederic Beseme	Head of CSR	21,99k	N/A	1956
Jennifer Zinn	Executive Vice President of Clinical Operations	N/A	N/A	N/A
Charles K. Cooper	Executive VP & Chief Medical Officer	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries. It also provides a suite of software products and services that collect, analyze, and merge various sources of data to make decisions under the BIOMÉRIEUX VISION SUITE name; designs, manufactures, and maintains instruments and software; and designs and manufactures reagents for in vitro diagnostic tests. The company serves clinical and hospital laboratories, physicians, blood banks, vets, and industrial control laboratories. bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

Corporate Governance

bioMérieux S.A.s ISS Governance QualityScore, Stand 1. April 2024, lautet 9. Die grundlegenden Scores sind Audit: 5, Vorstand: 8, Shareholderrechte: 8, Kompensation: 10.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.